WKEY vs. RXRX

Last updated Apr 1, 2026

Compare and contrast key facts about WISeKey International Holding AG (WKEY) and Recursion Pharmaceuticals, Inc. (RXRX).

Performance

WKEY vs. RXRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WISeKey International Holding AG (WKEY) and Recursion Pharmaceuticals, Inc. (RXRX). The values are adjusted to include any dividend payments, if applicable.

WKEY vs. RXRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
WKEY WISeKey International Holding AG	-21.78%	-13.31%	417.40%	-60.67%	-77.35%	-56.53%
RXRX Recursion Pharmaceuticals, Inc.	-24.94%	-39.50%	-31.44%	27.89%	-54.99%	-45.27%

Fundamentals

Market Cap WKEY : $25.69M RXRX : $1.62B
EPS WKEY : -$8.57 RXRX : -$1.39
PS Ratio WKEY : 0.78 RXRX : 19.09
PB Ratio WKEY : 0.82 RXRX : 1.43
Total Revenue (TTM) WKEY : $32.98M RXRX : $74.56M
Gross Profit (TTM) WKEY : $17.65M RXRX : $3.73M
EBITDA (TTM) WKEY : -$60.51M RXRX : -$579.69M

Returns By Period

In the year-to-date period, WKEY achieves a -21.78% return, which is significantly higher than RXRX's -24.94% return.

WKEY

• 1D: 12.45%
• 1M: -13.52%
• YTD: -21.78%
• 6M: -3.46%
• 1Y: 56.23%
• 3Y*: 5.70%
• 5Y*: -38.08%
• 10Y*: —

RXRX

• 1D: 8.10%
• 1M: -16.35%
• YTD: -24.94%
• 6M: -37.09%
• 1Y: -41.97%
• 3Y*: -22.79%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

WKEY vs. RXRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WKEY

WKEY Risk / Return Rank: 62
WKEY Sharpe Ratio Rank: 61
WKEY Sortino Ratio Rank: 71
WKEY Omega Ratio Rank: 64
WKEY Calmar Ratio Rank: 60
WKEY Martin Ratio Rank: 57

RXRX

RXRX Risk / Return Rank: 17
RXRX Sharpe Ratio Rank: 20
RXRX Sortino Ratio Rank: 22
RXRX Omega Ratio Rank: 23
RXRX Calmar Ratio Rank: 13
RXRX Martin Ratio Rank: 7

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WKEY vs. RXRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WISeKey International Holding AG (WKEY) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	WKEY	RXRX	Difference
Sharpe ratio Return per unit of total volatility	0.52	-0.50	+1.02
Sortino ratio Return per unit of downside risk	1.60	-0.38	+1.98
Omega ratio Gain probability vs. loss probability	1.18	0.96	+0.22
Calmar ratio Return relative to maximum drawdown	0.80	-0.81	+1.61
Martin ratio Return relative to average drawdown	1.48	-1.61	+3.09
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

WKEY vs. RXRX - Sharpe Ratio Comparison

The current WKEY Sharpe Ratio is 0.52, which is higher than the RXRX Sharpe Ratio of -0.50. The chart below compares the historical Sharpe Ratios of WKEY and RXRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	WKEY	RXRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.52	-0.50	+1.02
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.32	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.23	-0.40	+0.16

Correlation

The correlation between WKEY and RXRX is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

WKEY vs. RXRX - Dividend Comparison

Neither WKEY nor RXRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

WKEY vs. RXRX - Drawdown Comparison

The maximum WKEY drawdown since its inception was -98.63%, which is greater than RXRX's maximum drawdown of -93.13%. Use the drawdown chart below to compare losses from any high point for WKEY and RXRX.

Drawdown Indicators

	WKEY	RXRX	Difference
Max Drawdown Largest peak-to-trough decline	-98.63%	-93.13%	-5.50%
Max Drawdown (1Y) Largest decline over 1 year	-69.33%	-58.17%	-11.16%
Max Drawdown (5Y) Largest decline over 5 years	-97.91%	—	—
Current Drawdown Current decline from peak	-94.02%	-92.57%	-1.45%
Average Drawdown Average peak-to-trough decline	-76.32%	-74.76%	-1.56%
Ulcer Index Depth and duration of drawdowns from previous peaks	37.48%	29.28%	+8.20%

Volatility

WKEY vs. RXRX - Volatility Comparison

WISeKey International Holding AG (WKEY) has a higher volatility of 24.38% compared to Recursion Pharmaceuticals, Inc. (RXRX) at 14.77%. This indicates that WKEY's price experiences larger fluctuations and is considered to be riskier than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	WKEY	RXRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	24.38%	14.77%	+9.61%
Volatility (6M) Calculated over the trailing 6-month period	85.47%	54.53%	+30.94%
Volatility (1Y) Calculated over the trailing 1-year period	109.13%	84.44%	+24.69%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	121.29%	94.56%	+26.73%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	136.07%	94.56%	+41.51%

Financials